108 filings
8-K
AGTC
Applied Genetic Technologies Corp
1 Dec 22
Termination of a Material Definitive Agreement
8:49am
8-K
AGTC
Applied Genetic Technologies Corp
29 Nov 22
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation
8:46am
8-K
AGTC
Applied Genetic Technologies Corp
23 Nov 22
Other Events
8:32am
8-K
AGTC
Applied Genetic Technologies Corp
24 Oct 22
Syncona to Acquire Applied Genetic Technologies Corporation
9:14am
8-K
AGTC
Applied Genetic Technologies Corp
26 Aug 22
Departure of Directors or Certain Officers
4:09pm
8-K
m4utn bzr1
12 Aug 22
Departure of Directors or Certain Officers
4:05pm
8-K
wz2bgz
14 Jul 22
AGTC Announces Proposed Underwritten Public Offering
4:01pm
8-K
7syegj 68
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:21pm
8-K
95l1hy8
16 May 22
AGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa
4:13pm
8-K
sbqojg8z
9 May 22
Entry into a Material Definitive Agreement
4:09pm
8-K
hdgakd6
23 Mar 22
AGTC Announces Proposed Public Offering of Common Stock
4:23pm
8-K
w19 vbf6ggoo06w
2 Mar 22
Departure of Directors or Certain Officers
4:18pm
8-K
2a8htgkun4xz fk
14 Feb 22
Results of Operations and Financial Condition
7:15am
8-K
0mfn cswgz
8 Feb 22
Regulation FD Disclosure
7:14am
8-K
bsqz5qir vchj2ligut
11 Jan 22
Company on track to report three-month interim study results, including visual acuity, visual sensitivity, mobility and safety data, in Q2 2022
8:10am
8-K
7212 qmxh
6 Dec 21
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
8:11am
8-K/A
vnccgaqzjumu
12 Nov 21
Departure of Directors or Certain Officers
4:13pm
8-K
1j5k9fw50uv28
9 Nov 21
Results of Operations and Financial Condition
7:13am
8-K
s5v85 irdms
14 Oct 21
AGTC Announces Two Key Leadership Team Appointments
5:14pm
8-K
hlq5es sudkr4lhof7s
23 Sep 21
Results of Operations and Financial Condition
4:11pm